Chrome Extension
WeChat Mini Program
Use on ChatGLM

Fexofenadine HCl Microspheres – Can it be the First Line therapy for Allergic Disorders ?

Paroma Arefin,Md Shehan Habib,Mohammad Mostafa,Dipankar Chakraborty, reebash Chandra Bhattacharjee,Md Saidul Arefin, Debabrata Karmakar

Biosciences Biotechnology Research Asia(2021)

Cited 0|Views6
No score
Abstract
Fexofenadine HCl is a second-generation antihistamine which is commonly used for allergic disorders. But it has low bioavailability. Intranasal corticosteroids (INCs) and Immunotherapy and Allergen Specific Immunotherapy (ASIT) are now commonly being suggested for the treatment of allergic disorders. Despite the fact that current treatment alternatives have been in use for decades, patient quality of life has remained static. The treatment options are not much explored for their respective adverse effects. Therefore, they are in desperate need of research. Fexofenadine HCl is available in the form of a suspension, tablet, or capsule. In our current study, we have explored whether microspheres can be the perfect dosage form of Fexofenadine HCl to treat allergic disorders considering the pharmacokinetics of the drug, available dosage forms options and the probable side effects of the current therapies.
More
Translated text
Key words
Treatment
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined